학술논문
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab
Document Type
Article
Author
Shafat, T.; Nesher, L.; Abuhasira, R.; Spallone, A.; Chemaly, R.F.; Batista, M.V.; Atamna, A.; Ramos-Ramos, J.C.; Keske, Ş.; Grupel, D.; Oster, Y.; Zahran, S.; Horwitz, E.; Porges, T.; Belkin, A.; Deri, O.; Horowitz, N.A.; Khatib, H.; Cortez, A.C.; Brosh-Nissimov, T.; Segman, Y.; Ishay, L.; Cohen, R.; Chowers, M.; Rogozin, E.; Oren, N.C.; Barchad, O.W.
Source
In: Cancer Medicine . (Cancer Medicine, February 2024, 13(3))
Subject
Language
English
ISSN
20457634